Lifecore Biomedical, Inc. De annual debt-to-equity ratio
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2024
2025
Lifecore Biomedical, Inc. De Debt-to-Equity Ratio Growth & History (LFCR)
Lifecore Biomedical, Inc. De's debt-to-equity ratio was 103.39 for fiscal 2025.
View full Lifecore Biomedical, Inc. De company overviewLifecore Biomedical, Inc. De annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 · May 25 | 2025-05-25 | 103.39 | 93.60 | +955.47% |
| 2024 | 2024-05-26 | 9.80 | — | — |
| 2022 | 2022-05-29 | 0.18 | −0.78 | −81.35% |
| 2021 | 2021-05-30 | 0.95 | 0.33 | +52.36% |
| 2020 | 2020-05-31 | 0.63 | 0.25 | +67.89% |
| 2019 | 2019-05-26 | 0.37 | 0.19 | +104.38% |
| 2018 | 2018-05-27 | 0.18 | −0.04 | −19.09% |
| 2017 | 2017-05-28 | 0.23 | −0.05 | −17.67% |
| 2016 | 2016-05-29 | 0.27 | 0.08 | +40.54% |
| 2015 | 2015-05-31 | 0.19 | 0.03 | +15.00% |
| 2014 | 2014-05-25 | 0.17 | −0.06 | −24.96% |
| 2013 | 2013-05-28 | 0.23 | −0.09 | −28.62% |
| 2012 | 2012-05-27 | 0.32 | 0.17 | +116.80% |
| 2011 | 2011-05-29 | 0.15 | — | — |
Lifecore Biomedical, Inc. De quarterly debt-to-equity ratio
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q2.13
Q3.13
As of May 26, 2013
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q2.24
Q3.24
Q4.24
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 · May 25 | 2025-05-25 | 103.39 | 93.60 | +955.47% |
| Q3 2025 · Feb 23 | 2025-02-23 | 61.39 | 55.90 | +1018.04% |
| Q2 2025 | 2024-11-24 | 7.20 | −58.14 | −88.98% |
| Q4 2024 | 2024-05-26 | 9.80 | — | — |
| Q3 2024 | 2024-02-25 | 5.49 | 2.67 | +94.43% |
| Q2 2024 | 2023-11-26 | 65.35 | 64.01 | +4797.87% |
| Q3 2023 | 2023-02-26 | 2.82 | 2.27 | +409.91% |
| Q2 2023 | 2022-11-27 | 1.33 | 0.54 | +67.80% |
| Q1 2023 | 2022-08-28 | 1.23 | 0.59 | +92.02% |
| Q4 2022 | 2022-05-29 | 0.18 | −0.78 | −81.35% |
| Q3 2022 | 2022-02-27 | 0.55 | −0.16 | −21.87% |
| Q2 2022 | 2021-11-28 | 0.80 | 0.35 | +78.27% |
| Q1 2022 | 2021-08-29 | 0.64 | 0.16 | +34.61% |
| Q4 2021 | 2021-05-30 | 0.95 | 0.33 | +52.36% |
| Q3 2021 | 2021-02-28 | 0.71 | 0.12 | +19.50% |
| Q2 2021 | 2020-11-29 | 0.45 | −0.15 | −24.95% |
| Q1 2021 | 2020-08-30 | 0.47 | −0.01 | −1.90% |
| Q4 2020 | 2020-05-31 | 0.63 | 0.25 | +67.89% |
| Q3 2020 | 2020-02-23 | 0.59 | 0.21 | +55.55% |
| Q2 2020 | 2019-11-24 | 0.59 | 0.42 | +247.09% |
| Q1 2020 | 2019-08-25 | 0.48 | 0.31 | +174.33% |
| Q4 2019 | 2019-05-26 | 0.37 | 0.19 | +104.38% |
| Q3 2019 | 2019-02-24 | 0.38 | 0.19 | +100.88% |
| Q2 2019 | 2018-11-25 | 0.17 | −0.04 | −18.31% |
| Q1 2019 | 2018-08-26 | 0.18 | −0.04 | −18.58% |
| Q4 2018 | 2018-05-27 | 0.18 | −0.04 | −19.09% |
| Q3 2018 | 2018-02-25 | 0.19 | −0.04 | −19.08% |
| Q2 2018 | 2017-11-26 | 0.21 | −0.04 | −14.56% |
| Q1 2018 | 2017-08-27 | 0.22 | −0.04 | −16.42% |
| Q4 2017 | 2017-05-28 | 0.23 | −0.05 | −17.67% |
| Q3 2017 | 2017-02-26 | 0.23 | −0.06 | −20.96% |
| Q2 2017 | 2016-11-27 | 0.25 | 0.03 | +14.56% |
| Q1 2017 | 2016-08-28 | 0.26 | 0.08 | +41.85% |
| Q4 2016 | 2016-05-29 | 0.27 | 0.08 | +40.54% |
| Q3 2016 | 2016-02-28 | 0.30 | 0.11 | +56.78% |
| Q2 2016 | 2015-11-29 | 0.21 | 0.01 | +6.25% |
| Q1 2016 | 2015-08-30 | 0.18 | −0.01 | −6.11% |
| Q4 2015 | 2015-05-31 | 0.19 | 0.03 | +15.00% |
| Q3 2015 | 2015-03-01 | 0.19 | 0.01 | +4.78% |
| Q2 2015 | 2014-11-30 | 0.20 | 0.00 | +2.28% |
| Q1 2015 | 2014-08-31 | 0.19 | −0.02 | −8.19% |
| Q4 2014 | 2014-05-25 | 0.17 | — | — |
| Q3 2014 | 2014-02-23 | 0.18 | −0.07 | −27.02% |
| Q2 2014 | 2013-11-24 | 0.20 | −0.07 | −25.99% |
| Q1 2014 | 2013-08-25 | 0.21 | — | — |
| Q4 2013 | 2013-05-28 | 0.23 | −0.09 | −28.62% |
| As of May 26, 2013 | 2013-05-26 | 0.23 | −0.09 | −28.62% |
| Q3 2013 | 2013-02-24 | 0.25 | 0.14 | +121.95% |
| Q2 2013 | 2012-11-25 | 0.27 | 0.14 | +114.17% |
| Q4 2012 | 2012-05-27 | 0.32 | 0.17 | +116.80% |
| Q3 2012 | 2012-02-26 | 0.11 | — | — |
| Q2 2012 | 2011-11-27 | 0.12 | — | — |
| Q1 2012 | 2011-08-28 | 0.13 | — | — |
| Q4 2011 | 2011-05-29 | 0.15 | — | — |
Lifecore Biomedical, Inc. De debt-to-equity ratio trends
Over the last five fiscal years, Lifecore Biomedical, Inc. De's debt-to-equity ratio increased from 0.63 to 103.39, a change of 102.77. The latest reported quarter, Q4 2025 · May 25, shows 103.39.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lifecore Biomedical, Inc. De source filings ↗